Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics.

Mohebnasab, Maedeh and Eriksson, Oskar and Persson, Barbro and Sandholm, Kerstin and Mohlin, Camilla and Huber-Lang, Markus and Keating, Brendan J and Ekdahl, Kristina N and Nilsson, Bo (2019) Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics. Front Immunol, 10. 2539 - ?.

[img]
Preview
PDF
Available under License : See the attached license file.

Download (735kB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)

Abstract

Aberrations in complement system functions have been identified as either direct or indirect pathophysiological mechanisms in many diseases and pathological conditions, such as infections, autoimmune diseases, inflammation, malignancies, and allogeneic transplantation. Currently available techniques to study complement include quantification of (a) individual complement components, (b) complement activation products, and (c) molecular mechanisms/function. An emerging area of major interest in translational studies aims to study and monitor patients on complement regulatory drugs for efficacy as well as adverse events. This area is progressing rapidly with several anti-complement therapeutics under development, in clinical trials, or already in clinical use. In this review, we summarized the appropriate indications, techniques, and interpretations of basic complement analyses, exemplified by a number of clinical disorders.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: Article
Status: Published
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Mohebnasab, MaedehMAM1236@pitt.eduMAM12360000-0001-6623-9514
Eriksson, Oskar
Persson, Barbro
Sandholm, Kerstin
Mohlin, Camilla
Huber-Lang, Markus
Keating, Brendan J
Ekdahl, Kristina N
Nilsson, Bo
Date: 14 October 2019
Date Type: Acceptance
Journal or Publication Title: Front Immunol
Volume: 10
Page Range: 2539 - ?
DOI or Unique Handle: 10.3389/fimmu.2019.02539
Schools and Programs: School of Medicine > Pathology
Refereed: Yes
Uncontrolled Keywords: CV%, clinical trial, functional assays, immunoassays, laboratory investigation, Clinical Trials as Topic, Complement Activation, Complement C1 Inhibitor Protein, Complement C5, Complement System Proteins, Humans, Receptors, Complement, Signal Transduction
Date Deposited: 29 Aug 2022 17:09
Last Modified: 06 Sep 2022 13:55
URI: http://d-scholarship.pitt.edu/id/eprint/43674

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com


Actions (login required)

View Item View Item